Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H

Cell Research

Volumn 24, Issue 6, 2014, Pages 727-741

  Shen, Tao ^b,c   Sun, Chuang ^b   Zhang, Zhengmao ^b   Xu, Ningyi ^a   Duan, Xueyan ^b   Feng, Xin Hua ^a,b   Lin, Xia ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

phosphorylation; protein phosphatases; signal transduction; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PPM1H PROTEIN, HUMAN; PROTEIN BINDING; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; HEK293 CELLS; HUMANS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84901844054     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2014.48     Document Type: Article

References (52)

1. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-899.
2. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242:1528-1534. (Pubitemid 19023695)
3. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8:133-146.
4. Cohen MM Jr. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN. Am J Med Genet 2002; 109:87-92.
5. Soderberg SS, Karlsson G, Karlsson S. Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling. Ann NY Acad Sci 2009; 1176:55-69.
6. ten Dijke P. Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 2006; 22 Suppl 1:S7-S11. (Pubitemid 44298363)
7. Wan M, Cao X. BMP signaling in skeletal development. Biochem Biophys Res Commun 2005; 328:651-657. (Pubitemid 40208302)
8. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005; 16:251-263. (Pubitemid 40910315)
9. Kishigami S, Mishina Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 2005; 16:265-278. (Pubitemid 40910316)
10. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22:233-241. (Pubitemid 40136452)
11. Hardwick JC, Kodach LL, Offerhaus GJ, van den Brink GR. Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 2008; 8:806-812.
12. Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 2006; 26:1712-1720. (Pubitemid 44305323)
13. Lories RJ, Luyten FP. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 2005; 16:287-298. (Pubitemid 40910318)
14. Senta H, Park H, Bergeron E, et al. Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations. Cytokine Growth Factor Rev 2009; 20:213-222.
15. Maciel TT, Kempf H, Campos AH. Targeting bone morphogenetic protein signaling on renal and vascular diseases. Curr Opin Nephrol Hypertens 2010; 19:26-31.
16. Yanagita M. BMP modulators regulate the function of BMP during body patterning and disease progression. Biofactors 2009; 35:113-119.
17. Kodach LL, Bleuming SA, Musler AR, et al. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 2008; 112:300-306.
18. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700. (Pubitemid 36724933)
19. de Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004; 15:1-11. (Pubitemid 38121286)
20. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659-693. (Pubitemid 41740650)
21. Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002; 277:4883-4891. (Pubitemid 34968524)
22. Wrighton KH, Lin X, Feng XH. Phospho-control of TGF-beta superfamily signaling. Cell Res 2009; 19:8-20.
23. Lin X, Duan X, Liang YY, et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 2006; 125:915-928. (Pubitemid 43795197)
24. Duan X, Liang YY, Feng XH, Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 2006; 281:36526-36532. (Pubitemid 46042119)
25. Yu J, He X, Chen YG, et al. Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. J Biol Chem 2013; 288:79-88.
26. Knockaert M, Sapkota G, Alarcon C, Massague J, Brivanlou AH. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci USA 2006; 103:11940-11945. (Pubitemid 44215790)
27. Chen HB, Shen J, Ip YT, Xu L. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev 2006; 20:648-653.
28. Labes M, Roder J, Roach A. A novel phosphatase regulating neurite extension on CNS inhibitors. Mol Cell Neurosci 1998; 12:29-47. (Pubitemid 28524288)
29. Sugiura T, Noguchi Y, Sakurai K, Hattori C. Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L. Cancer Biol Ther 2008; 7:285-292. (Pubitemid 351590438)
30. Lee-Hoeflich ST, Pham TQ, Dowbenko D, et al. PPM1H is a p27 phosphatase implicated in trastuzumab resistance. Cancer Discov 2011; 1:326-337.
31. Hu CD, Kerppola TK. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 2003; 21:539-545. (Pubitemid 36532019)
32. Hofbauer LC, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 1998; 250:776-781. (Pubitemid 28484803)
33. Zhao M, Qiao M, Harris SE, et al. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 2004; 279:12854-12859. (Pubitemid 38445859)
34. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 2000; 113 ( Pt 22):3897-3905. (Pubitemid 32194515)
35. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147. (Pubitemid 29282067)
36. Komori T. Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol 2010; 658:43-49.
37. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108:17-29. (Pubitemid 34137009)
38. Benezra R, Davis RL, Lassar A, et al. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann NY Acad Sci 1990; 599:1-11. (Pubitemid 20302592)
39. Tapscott SJ, Davis RL, Lassar AB, Weintraub H. MyoD: a regulatory gene of skeletal myogenesis. Adv Exp Med Biol 1990; 280:3-5; discussion 5-6.
40. Ludolph DC and Konieczny SF. Transcription factor families: muscling in on the myogenic program. FASEB J 1995; 9:1595-1604. (Pubitemid 26013197)
41. Molkentin JD, Olson EN. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA 1996; 93:9366-9373. (Pubitemid 26296613)
42. Yu J, He S, Friedman JS, et al. Altered expression of genes of the Bmp/Smad and Wnt/calcium signaling pathways in the cone-only Nrl-/- mouse retina, revealed by gene profiling using custom cDNA microarrays. J Biol Chem 2004; 279:42211-42220. (Pubitemid 39313670)
43. Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8:970-982. (Pubitemid 350174642)
44. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009; 136:3699-3714.
45. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19:2783-2810. (Pubitemid 41739965)
46. Sapkota G, Knockaert M, Alarcon C, et al. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small Cterminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem 2006; 281:40412-40419. (Pubitemid 46041844)
47. Wrighton KH, Willis D, Long J, et al. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J Biol Chem 2006; 281:38365-38375. (Pubitemid 46041960)
48. Dai F, Lin X, Chang C, Feng XH. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling. Dev Cell 2009; 16:345-357.
49. Pangas SA, Li X, Umans L, et al. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 2008; 28:248-257.
50. Lin X, Liang M, Feng XH. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 2000; 275:36818-36822. (Pubitemid 32002092)
51. Lin X, Liang YY, Sun B, et al. Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic proteininduced transcription. Mol Cell Biol 2003; 23:9081-9093. (Pubitemid 37499798)
52. Feng XH, Lin X, Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J 2000; 19:5178-5193. Republic of China